Abstract
Evaluation of a community-based subcutaneous furosemide service for the treatment of advanced heart failure. We have initiated a community-based subcutaneous furosemide service for the treatment of advanced heart failure. In patients with end-stage heart failure, there is some evidence which suggests that furosemide can be given subcutaneously to relieve symptoms and avoid hospital admission. Our treatment guidelines were developed in collaboration with cardiologists, specialist nurses, palliative care and community nursing teams. All patients have a comprehensive emergency healthcare …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
